Tchaikapharma High Quality Medicines AD (BUL:THQM)
Bulgaria
· Delayed Price · Currency is BGN 17.13
+0.57 (3.47%)
At close: Jul 7, 2025
BUL:THQM Income Statement
Financials in millions BGN. Fiscal year is January - December.
Millions BGN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 55.97 | 53.14 | 48.51 | 43.15 | 42.43 | 40.11 | Upgrade
|
| 55.97 | 53.14 | 48.51 | 43.15 | 42.43 | 40.11 | Upgrade
| |
Revenue Growth (YoY) | 15.96% | 9.54% | 12.44% | 1.69% | 5.80% | 15.50% | Upgrade
|
Cost of Revenue | 17.23 | 20.32 | 33.54 | 12.81 | 30.77 | 30.01 | Upgrade
|
Gross Profit | 38.74 | 32.82 | 14.98 | 30.34 | 11.67 | 10.1 | Upgrade
|
Selling, General & Admin | 29.86 | 24.73 | 7.33 | 23.99 | 5.68 | 4.96 | Upgrade
|
Other Operating Expenses | 0.29 | 0.3 | 0.83 | -0.27 | 0.65 | 0.32 | Upgrade
|
Operating Expenses | 32.76 | 27.55 | 10.97 | 27.29 | 10.21 | 9.51 | Upgrade
|
Operating Income | 5.99 | 5.27 | 4.01 | 3.05 | 1.46 | 0.59 | Upgrade
|
Interest Expense | -0.56 | -0.59 | -0.55 | -0.28 | -0.27 | -0.24 | Upgrade
|
Interest & Investment Income | 0.48 | 0.48 | 0.46 | 0.47 | 0.46 | 0.45 | Upgrade
|
Currency Exchange Gain (Loss) | -0.07 | -0.09 | -0.01 | -0.07 | -0.06 | -0.03 | Upgrade
|
Other Non Operating Income (Expenses) | -0.04 | -0.04 | -0.04 | -0.04 | -0.02 | -0.15 | Upgrade
|
EBT Excluding Unusual Items | 5.79 | 5.03 | 3.87 | 3.13 | 1.56 | 0.62 | Upgrade
|
Pretax Income | 5.79 | 5.03 | 3.87 | 3.13 | 1.56 | 0.62 | Upgrade
|
Income Tax Expense | 0.6 | 0.54 | 0.47 | 0.34 | 0.17 | 0.2 | Upgrade
|
Net Income | 5.19 | 4.49 | 3.4 | 2.79 | 1.4 | 0.43 | Upgrade
|
Net Income to Common | 5.19 | 4.49 | 3.4 | 2.79 | 1.4 | 0.43 | Upgrade
|
Net Income Growth | 77.35% | 32.12% | 21.86% | 99.86% | 226.17% | -83.33% | Upgrade
|
Shares Outstanding (Basic) | 97 | 96 | 93 | 93 | 93 | 67 | Upgrade
|
Shares Outstanding (Diluted) | 97 | 96 | 93 | 93 | 93 | 67 | Upgrade
|
Shares Change (YoY) | 4.22% | 3.38% | - | - | 38.72% | -24.86% | Upgrade
|
EPS (Basic) | 0.05 | 0.05 | 0.04 | 0.03 | 0.02 | 0.01 | Upgrade
|
EPS (Diluted) | 0.05 | 0.05 | 0.04 | 0.03 | 0.02 | 0.01 | Upgrade
|
EPS Growth | 70.16% | 27.80% | 21.87% | 99.86% | 135.13% | -77.82% | Upgrade
|
Free Cash Flow | 1.07 | 1.2 | 0.96 | 0.88 | 0.45 | 0.58 | Upgrade
|
Free Cash Flow Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
Gross Margin | 69.22% | 61.76% | 30.87% | 70.31% | 27.49% | 25.18% | Upgrade
|
Operating Margin | 10.70% | 9.92% | 8.26% | 7.06% | 3.43% | 1.47% | Upgrade
|
Profit Margin | 9.28% | 8.45% | 7.01% | 6.47% | 3.29% | 1.07% | Upgrade
|
Free Cash Flow Margin | 1.92% | 2.25% | 1.97% | 2.04% | 1.06% | 1.44% | Upgrade
|
EBITDA | 8.56 | 7.77 | 6.81 | 6.38 | 5.3 | 4.82 | Upgrade
|
EBITDA Margin | 15.30% | 14.62% | 14.04% | 14.78% | 12.50% | 12.02% | Upgrade
|
D&A For EBITDA | 2.58 | 2.5 | 2.8 | 3.33 | 3.85 | 4.23 | Upgrade
|
EBIT | 5.99 | 5.27 | 4.01 | 3.05 | 1.46 | 0.59 | Upgrade
|
EBIT Margin | 10.70% | 9.92% | 8.26% | 7.06% | 3.43% | 1.47% | Upgrade
|
Effective Tax Rate | 10.36% | 10.73% | 12.14% | 10.92% | 10.74% | 31.41% | Upgrade
|
Revenue as Reported | 2.88 | - | - | - | 42.56 | 40.39 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.